Atea Pharmaceuticals Inc (AVIR)

Investing Cash Flow

$34.32M

Quarterly · Period ending: · USD

AVIR logo

AVIR Investing Cash Flow

Latest reported$34.32M
AVIR Quarterly Cash from Investing ($0.00 → $34.32M)
High-resolution chart · PNG

AVIR investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Atea Pharmaceuticals Inc Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
34,315,000
29,738,000
46,592,000
41,303,000
15,290,000
85,608,000
-3,370,000
-122,013,000
124,686,000
56,802,000
27,771,000
-58,513,000
46,565,000
24,480,000
33,488,000
-486,975,000
-1,879,000
-44,000
-4,000
0
0
0
-5,000
-15,000
-6,000
0
0
-2,000
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.